Lifeward Ltd. Restricted Cash and Cash Equivalents, Noncurrent
Lifeward Ltd. (LFWD) had Restricted Cash and Cash Equivalents, Noncurrent of $440.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-14
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $440.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $407.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $410.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $404.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $440.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $407.00K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $410.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $404.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $384.00K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $360.00K 10-Q · filed 2026-05-20 |
| 2024-12-31 | $362.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $361.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $356.00K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $360.00K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $709.00K 10-K · filed 2026-03-18 |
| 2022-12-31 | $659.00K 10-K · filed 2025-03-07 |
| 2021-12-31 | $713.00K 10-K · filed 2024-02-27 |
| 2020-12-31 | $704.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |